A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone

E Vieta, E Nieto, A Autet, AR Rosa… - The World Journal of …, 2008 - Taylor & Francis
Background: Risperidone is the first atypical antipsychotic to become available in a long-
acting, injectable formulation. This is the first prospective study to assess the effectiveness of …
被引用次数：70 相关文章

A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone.

E Vieta, E Nieto, A Autet, AR Rosa… - The World Journal of …, 2008 - europepmc.org
Background Risperidone is the first atypical antipsychotic to become available in a long-
acting, injectable formulation. This is the first prospective study to assess the effectiveness of …

A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone

E Vieta, E Nieto, A Autet, AR Rosa… - World journal of …, 2008 - safetylit.org
BACKGROUND: Risperidone is the first atypical antipsychotic to become available in a long-
acting, injectable formulation. This is the first prospective study to assess the effectiveness of …
[PDF] psu.edu

[PDF][PDF] A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone

E VIETA, E NIETO, A AUTET, AR ROSA - Is the roller coaster ride in …, 2008 - Citeseer
Background: Risperidone is the first atypical antipsychotic to become available in a long-
acting, injectable formulation. This is the first prospective study to assess the effectiveness of …
[PDF] researchgate.net

[PDF][PDF] A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone

E VIETA, E NIETO, A AUTET… - Is the roller coaster ride in …, 2008 - researchgate.net
Background: Risperidone is the first atypical antipsychotic to become available in a long-
acting, injectable formulation. This is the first prospective study to assess the effectiveness of …

A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone

E Vieta, E Nieto, A Autet, AR Rosa… - The world journal …, 2008 - pubmed.ncbi.nlm.nih.gov
Background Risperidone is the first atypical antipsychotic to become available in a long-
acting, injectable formulation. This is the first prospective study to assess the effectiveness of …
[PDF] academia.edu

[PDF][PDF] A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone

E VIETA, E NIETO, A AUTET… - Is the roller coaster ride in …, 2008 - academia.edu
Background: Risperidone is the first atypical antipsychotic to become available in a long-
acting, injectable formulation. This is the first prospective study to assess the effectiveness of …
[PDF] researchgate.net

[PDF][PDF] A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone

E VIETA, E NIETO, A AUTET… - Is the roller coaster ride in …, 2008 - researchgate.net
Background: Risperidone is the first atypical antipsychotic to become available in a long-
acting, injectable formulation. This is the first prospective study to assess the effectiveness of …